← Evidence map

TrialCephalalgia : an international journal of headache2022

Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.

Uwe Reuter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

75 papers cite itlatest 60 shown

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34743579